跳至主要内容
临床试验/CTRI/2019/08/020883
CTRI/2019/08/020883招募中不适用

A comparative study of effectiveness of Intralesional Radiofrequency and ultra pulse carbondioxide laser ablation in keloid & hypertrophic scar

Department of dermatology Government Medical College Bhavnagar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年9月16日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
Excellent response (90 %- almost complete flattening)

研究概览

简要总结

Keloid and hypertrophic scars are caused by disturbance in normal healing process. Delay in wound healing, infection, foreign material in wound, tension on area, hormonal status, genetic constitution, etc. are few of the factors that affect the formation of keloid and its recurrence.

Available different treatment options:

intralesional steroid,

surgical excision,

cryotherapy,

pressure therapy,

silicone gel sheet application,

radiotherapy,

laser therapy,

botulinum toxin, etc.

But, none of the therapeutic option for the treatment of keloid has been found completely effective and satisfactory. Mostly, combination of treatments is necessary for better outcome.

Surgical excision with modification often tried for good cosmesis and/or symptom relief, but mostly complicated by recurrence of keloid.

radiofrequency heating is used to create targeted coagulation and necrosis that result in reduction of volume in treated area.

In co2 laser, 10,600nm laser light is used for selective photothermolysis of full thickness tissue.

Intralesional injection following the procedure is given for suppression of tissue regrowth.

The procedure will be done under local anesthesia.

Study Methodology:

Keloid or hypertrophic scar will be photographed, measured and assessed with other different scales (VSS, POSAS) and noted on Case Record Form with Consent of the Participant or Guardian (in case of minor) after full explanation of  the procedure, side effect, other modalities, outcome and other queries.

The chosen procedure will be repeated every monthly (in needed) followed by intralesional injection for consequently 3 months after reassessment of the lesion. Intralesional injection will be carried out monthly for total duration of 6 months(counting from 1st procedure done)

Side effects:

Pain/ itching at treatment site

Edema/ ulcer/ bullae at treatment site

Post procedure advice:

Do not touch/ press repeatedly and scratch over treatment area

On notice of above side effect, inform your treatment doctor as soon as possible

Avoid direct exposure of wound to sunlight and dust

Complete the given medicines

Be on regular follow up for further treatment

Outcome:

Treatment site may not look completely as normal surrounding skin

One or more treatment at same site may be needed at same site.

Recurrence of keloid may happen at treatment site which depends upon physical nature of the person

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients with Keloid and hypertrophic scar Progressive or Stationary lesion Size <10 cm in any dimension No previous treatment in last 6 weeks.

排除标准

  • Pedunculated lesion Sensitivity to local anesthetic Pregnant females Infected or secondary changes on surface (e.g. excoriation/ eczema) Person with Pacemaker Person with unstable general condition Patient not willing for consent and follow up Patient in need of alternative treatment during the treatment course.

结局指标

主要结局

Excellent response (90 %- almost complete flattening)

时间窗: 28 weeks

Good response (71-90 % Significant flattening)

时间窗: 28 weeks

Moderate response (51-70 % Adequate flattening)

时间窗: 28 weeks

Poor response (≤50 % Inadequate flattening)

时间窗: 28 weeks

次要结局

  • Size(Height)

研究者

发起方
Department of dermatology Government Medical College Bhavnagar
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验